Quantitative MRI can detect subclinical disease progression in muscular dystrophy

Journal of Neurology

Volumn 259, Issue 8, 2012, Pages 1648-1654

  Fischmann, Arne ^a   Hafner, Patricia ^a   Fasler, Susanne ^a   Gloor, Monika ^a   Bieri, Oliver ^a   Studler, Ueli ^a   Fischer, Dirk ^a,b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Follow up; MRI; Neuromuscular disease; OPMD

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EXTENSOR DIGITORUM LONGUS MUSCLE; FEMALE; FOLLOW UP; GASTROCNEMIUS MUSCLE; GRACILIS MUSCLE; HUMAN; INTERMETHOD COMPARISON; MALE; MOTOR PERFORMANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCULOPHARYNGEAL MUSCULAR DYSTROPHY; PERONEUS MUSCLE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RECTUS FEMORIS MUSCLE; SOLEUS MUSCLE; TIBIALIS ANTERIOR MUSCLE; TIBIALIS POSTERIOR MUSCLE; VASTUS LATERALIS MUSCLE; VASTUS MEDIALIS MUSCLE;

ADULT; AGED; DIFFUSION TENSOR IMAGING; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCULAR DYSTROPHY, OCULOPHARYNGEAL; PILOT PROJECTS; YOUNG ADULT;

EID: 84867333250     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-011-6393-2     Document Type: Article

References (18)

1. Brais B (2009) Oculopharyngeal muscular dystrophy: a polyalanine myopathy. Curr Neurol Neurosci Rep 9:76-82
2. Fischmann A, Gloor M, Fasler S, Haas T, Rodoni Wetzel R, Bieri O, Wetzel S, Heinimann K, Scheffler K, Fischer D (2011) Muscular involvement assessed by MRI correlates to motor function measurement values in oculopharyngeal muscular dystrophy. J Neurol 258:1333-1340. doi:10.1007/s00415-011-5937-9
3. Mercuri E, Mayhew A, Muntoni F, Messina S, Straub V, Van Ommen GJ, Voit T, Bertini E, Bushby K, Network TREATNMDN (2008) Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD; report of three expert workshops: TREAT-NMD/ENMC workshop on outcome measures, 12th-13th May 2007, Naarden, The Netherlands; TREATNMD workshop on outcome measures in experimental trials for DMD, 30th June-1st July 2007, Naarden, The Netherlands; conjoint Institute of Myology TREAT-NMD meeting on physical activity monitoring in neuromuscular disorders, 11th July 2007, Paris, France. Neuromuscul Disord 18:894-903. doi:10.1016/j.nmd.2008.07.003
4. Kim HK, Laor T, Horn PS, Wong B (2010) Quantitative assessment of the T2 relaxation time of the gluteus muscles in children with Duchenne muscular dystrophy: a comparative study before and after steroid treatment. Korean J Radiol 11:304-311. doi:10.3348/kjr.2010.11.3.304
5. Gloor M, Fasler S, Fischmann A, Haas T, Bieri O, Heinimann K, Wetzel SG, Scheffler K, Fischer D (2011) Quantification of fat infiltration in oculopharyngeal muscular dystrophy: comparison of three MR imaging methods. JMRI 33:203-210. doi:10.1002/jmri.22431
6. Paradas C, Llauger J, Diaz-Manera J, Rojas-García R, De Luna N, Iturriaga C, Márquez C, Usón M, Hankiewicz K, Gallardo E, Illa I (2010) Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies. Neurology 75:316-323. doi:10.1212/WNL.0b013e3181ea1564
7. Vuillerot C, Girardot F, Payan C, Fermanian J, Iwaz J, Lattre DE, Berard C (2009) Monitoring changes and predicting loss of ambulation in duchenne muscular dystrophy with the motor function measure. Dev Med Child Neurol. doi:10.1111/j.1469-8749.2009.03316.x
8. Bérard C, Payan C, Hodgkinson I, Fermanian J, Group MFMCS (2005) A motor function measure for neuromuscular diseases construction and validation study. Neuromuscul Disord 15:463-470
9. Fischer D, Kley RA, Strach K, Meyer C, Sommer T, Eger K, Rolfs A, Meyer W, Pou A, Pradas J, Heyer CM, Grossmann A, Huebner A, Kress W, Reimann J, Schröder RJ, Eymard B, Fardeau M, Udd B, Goldfarb L, Vorgerd M, Olivé M (2008) Distinct muscle imaging patterns in myofibrillar myopathies. Neurology 71:758-765. doi:10.1212/01.wnl.0000324927.28817.9b
10. Coté C, Hiba B, Hebert LJ, Vial C, Remec JF, Janier M, Puymirat J (2011) MRI of tibialis anterior skeletal muscle in myotonic dystrophy type 1. Can J Neurol Sci 38:112-118
11. Sinclair C, Morrow J, Fischmann A, Hanna M, Reilly M, Yousry T, Golay X, Thornton J (2011) Skeletal muscle MRI-determined fat fraction and myometric strength in inclusion body myositis and Charcot-Marie-Tooth disease Type 1A. Neuromuscul Disord 21:S5. doi:10.1016/S0960-8966 (11) 70014-1
12. Bryan WW, Reisch JS, McDonald G, Herbelin LL, Barohn RJ, Fleckenstein JL (1998) Magnetic resonance imaging of muscle in amyotrophic lateral sclerosis. Neurology 51:110-113
13. Gaeta M, Scribano E, Mileto A, Mazziotti S, Rodolico C, Toscano A, Settineri N, Ascenti G, Blandino A (2011) Muscle fat fraction in neuromuscular disorders: dual-echo dual-flip-angle spoiled gradient-recalled mr imaging technique for quantification-a feasibility study. Radiology 259:487-494. doi:10.1148/radiol.10101108
14. Meola G, Bugiardini E, Cardani R (2011) Muscle biopsy. J Neurol. doi:10.1007/s00415-011-6193-8
15. Huang Y, Majumdar S, Genant HK, Chan WP, Sharma KR, Yu P, Mynhier M, Miller RG (1994) Quantitative MR relaxometry study of muscle composition and function in Duchenne muscular dystrophy. JMRI 4:59-64
16. Patten C, Meyer RA, Fleckenstein JL (2003) T2 mapping of muscle. Semin Musculoskel Radiol 7:297-305. doi:10.1055/s-2004-815677
17. Skinner TE, Glover GH (1997) An extended two-point Dixon algorithm for calculating separate water, fat, and B0 images. Magn Reson Med 37:628-630
18. Allerhand A (1966) Analysis of carr-purcell spin-echo nmr experiments on multiple-spin systems. I. the effect of homonuclear coupling. J Chem Phys 44:1-9